AIV Logo AIV Assistant

Loading...

 Logo ResMed Inc. - RMD Open ResMed Inc. in new tab

251.49 USD
P/E
25.77
EPS
9.76
Yield
0.87%
P/B
6.00
ROE
25.41
Beta
0.87
Target Price
293.47 USD

251.4900 USD

251.490 USD

Daily: +0.00%
Key Metrics

Earnings date: Jan. 29, 2026

P/E: 25.77

EPS: 9.76

Book Value: 41.94

Price to Book: 6.00

Debt/Equity: 13.83

% Insiders: 0.620%

Growth

Revenue Growth: 0.09%

Earnings Growth: 0.12%

Estimates

Forward P/E: 24.44

Forward EPS: 10.29

Target Mean Price: 293.47

Dividend

Dividend Yield: 0.87%

Annual dividends: 2.19 USD

Ex-Div. Date: Nov. 13, 2025

Payout: 22.31%

5y avg Yield: 0.83%

DCF Valuation

Tweak assumptions to recompute fair value for ResMed Inc. (RMD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

 Logo About ResMed Inc. - (RMD)

Country: United States

Sector: Health Care

Website: http://www.resmed.com

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Exchange Ticker
NYQ (United States) RMD
Dividend Yield

0.87% (5y avg: 0.83%)

Annual Dividends

2.19 USD

Next ex. div date

Nov. 13, 2025

Payout Ratio

22.31%

Historical Dividends
Year Total Dividends
2026 1.74 USD
2025 2.26 USD
2024 2.02 USD
2023 1.84 USD
2022 1.72 USD
2021 1.62 USD
2020 1.56 USD
2019 1.52 USD
2018 1.44 USD
2017 1.36 USD
2016 1.26 USD
2015 1.16 USD
2014 1.06 USD
2013 0.84 USD
2012 0.34 USD

Yearly aggregated dividends

Dividends

ResMed Inc.
Dec 18, 2025 Upcoming
Dividend
0.6 USD
ResMed Inc.
Sep 18, 2025 Paid
Dividend
0.6 USD
ResMed Inc.
Jun 12, 2025 Paid
Dividend
0.53 USD
ResMed Inc.
Mar 20, 2025 Paid
Dividend
0.53 USD

Historical Split Corporate Actions

Split Date Split Ratio to 1
April 3, 2000 2.000000
Oct. 3, 2005 2.000000
Aug. 31, 2010 2.000000
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion